Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 4
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers.
Álvarez-Sánchez L, Peña-Bautista C, Ferré-González L, Cubas L, Balaguer A, Casanova-Estruch B, Baquero M, Cháfer-Pericás C. Álvarez-Sánchez L, et al. Int J Mol Sci. 2023 Sep 15;24(18):14151. doi: 10.3390/ijms241814151. Int J Mol Sci. 2023. PMID: 37762457 Free PMC article.
Discordant Amyloid Status Diagnosis in Alzheimer's Disease.
García-Vallés L, Peña-Bautista C, Álvarez-Sánchez L, Ferrer-Cairols I, Baquero M, Cháfer-Pericás C. García-Vallés L, et al. Among authors: alvarez sanchez l. Biomedicines. 2022 Nov 10;10(11):2880. doi: 10.3390/biomedicines10112880. Biomedicines. 2022. PMID: 36359400 Free PMC article.
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis.
Peña-Bautista C, Álvarez-Sánchez L, Ferrer I, López-Nogueroles M, Cañada-Martínez AJ, Oger C, Galano JM, Durand T, Baquero M, Cháfer-Pericás C. Peña-Bautista C, et al. Among authors: alvarez sanchez l. Antioxidants (Basel). 2021 Jun 29;10(7):1043. doi: 10.3390/antiox10071043. Antioxidants (Basel). 2021. PMID: 34209667 Free PMC article.
Assessment of apolipoprotein E genotype for β-amyloid status prediction.
Peña-Bautista C, Álvarez-Sánchez L, García L, Baquero M, Cháfer-Pericás C. Peña-Bautista C, et al. Among authors: alvarez sanchez l. Curr Alzheimer Res. 2021;18(13):1032-1040. doi: 10.2174/1567205019666211223141524. Curr Alzheimer Res. 2021. PMID: 34951383
Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer's disease.
Peña-Bautista C, Álvarez-Sánchez L, Pascual R, Moreno MJ, Baquero M, Cháfer-Pericás C. Peña-Bautista C, et al. Among authors: alvarez sanchez l. Eur J Clin Invest. 2023 Mar;53(3):e13910. doi: 10.1111/eci.13910. Epub 2022 Nov 24. Eur J Clin Invest. 2023. PMID: 36401799
Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression.
Peña-Bautista C, Álvarez-Sánchez L, Ferrer-Cairols I, García-Vallés L, Baquero M, Cháfer-Pericás C. Peña-Bautista C, et al. Among authors: alvarez sanchez l. J Neurol. 2023 Oct;270(10):4585-4592. doi: 10.1007/s00415-023-11899-5. Epub 2023 Jul 28. J Neurol. 2023. PMID: 37505239
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.
Prats-Climent J, Gandia-Ferrero MT, Torres-Espallardo I, Álvarez-Sanchez L, Martínez-Sanchis B, Cháfer-Pericás C, Gómez-Rico I, Cerdá-Alberich L, Aparici-Robles F, Baquero-Toledo M, Rodríguez-Álvarez MJ, Martí-Bonmatí L. Prats-Climent J, et al. Among authors: alvarez sanchez l. J Med Syst. 2022 Jun 17;46(8):52. doi: 10.1007/s10916-022-01836-w. J Med Syst. 2022. PMID: 35713815 Free article.
16 results